About Compugen Ltd.
https://cgen.comCompugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
CEO
Eran Ophir
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 2 of 4
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
SILVERARC CAPITAL MANAGEMENT, LLC
Shares:3.31M
Value:$6.56M
RENAISSANCE TECHNOLOGIES LLC
Shares:1.41M
Value:$2.78M
MORGAN STANLEY
Shares:1.06M
Value:$2.1M
Summary
Showing Top 3 of 91
About Compugen Ltd.
https://cgen.comCompugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.89M ▲ | $8.13M ▲ | $-6.98M ▲ | -369.06% ▲ | $-0.07 ▲ | $-6.94M ▲ |
| Q2-2025 | $1.26M ▼ | $8.02M ▼ | $-7.34M ▼ | -584.09% ▼ | $-0.08 ▼ | $-7.36M ▲ |
| Q1-2025 | $2.28M ▲ | $8.28M | $-7.18M ▼ | -314.4% ▲ | $-0.08 ▼ | $-8.39M ▼ |
| Q4-2024 | $1.47M ▼ | $8.28M ▼ | $-6.12M ▼ | -415.84% ▼ | $-0.07 ▼ | $-7.48M ▼ |
| Q3-2024 | $17.13M | $9.04M | $1.28M | 7.45% | $0.01 | $4.5M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $86.09M ▼ | $97.84M ▼ | $54.02M ▼ | $43.83M ▼ |
| Q2-2025 | $93.88M ▼ | $106.53M ▼ | $56.27M ▼ | $50.26M ▼ |
| Q1-2025 | $103.75M ▲ | $115.44M ▲ | $58.34M ▼ | $57.11M ▲ |
| Q4-2024 | $103.25M ▼ | $115M ▼ | $60.08M ▼ | $54.91M ▼ |
| Q3-2024 | $112.71M | $123.52M | $63.03M | $60.49M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2023 | $-9.85M ▼ | $0 | $0 | $0 | $30.1M ▲ | $0 |
| Q2-2023 | $-9.28M ▲ | $0 | $0 | $0 | $-56.63M ▼ | $0 |
| Q1-2023 | $-9.34M ▼ | $0 ▲ | $0 ▼ | $0 ▲ | $62.9M ▲ | $0 ▲ |
| Q4-2022 | $-3.09M ▲ | $-23.03M ▼ | $40.39M ▲ | $-18.41M ▼ | $-1.06M ▼ | $-23.38M ▼ |
| Q3-2022 | $-11.75M | $0 | $0 | $0 | $0 | $0 |
CEO
Eran Ophir
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 2 of 4
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
SILVERARC CAPITAL MANAGEMENT, LLC
Shares:3.31M
Value:$6.56M
RENAISSANCE TECHNOLOGIES LLC
Shares:1.41M
Value:$2.78M
MORGAN STANLEY
Shares:1.06M
Value:$2.1M
Summary
Showing Top 3 of 91